申请人:Vanderbilt University
公开号:US10005728B2
公开(公告)日:2018-06-26
The present application, among other things, provides compounds that are capable of inhibiting the activity of anti-apoptotic Bcl-2 family proteins, for example, myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides pharmaceutical compositions as well as methods for using provided compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein. In some embodiments, a provided compound has the structure of formula I. In some embodiments, a provided compound has the structure of formula II.
本申请除其他外,提供了能够抑制抗凋亡 Bcl-2 家族蛋白(例如髓系细胞白血病-1(Mcl-1)蛋白)活性的化合物。本发明还提供了药物组合物以及使用所提供的化合物治疗以 Mcl-1 蛋白过度表达或失调为特征的疾病和病症(如癌症)的方法。在某些实施方案中,所提供的化合物具有式I的结构。